Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021
Back to Newsroom
Mentioned in this Article

Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021

Wednesday, June 9, 2021 2:00 AM
Share this article now
Topic:
Shareholder Meeting

ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will be hosting an investor webinar focused on the Company's various R&D programmes at 2.00pm BST / 9.00am EST on 17 June 2021.

The webinar is open to all existing and potential shareholders and those interested in attending may register via the following link, where following registration they will be provided with access details:

https://us02web.zoom.us/webinar/register/WN_9dDM5-NrRWe6eMAaiGtBLA

Participants may submit questions during the webinar or in advance via email to: [email protected]

For more information, please contact:

Midatech Pharma PLC
Stephen Stamp, CEO, CFO
Tel: +44 (0)29 20480180
www.midatechpharma.com
 
Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)
Freddy Crossley, Emma Earl (Corporate Finance)
Rupert Dearden (Corporate Broking)

Tel: +44 (0)20 7886 2500

Turner Pope Investments (TPI) Limited (Joint Broker)

Andrew Thacker / James Pope (Corporate Broking)
Tel: +44(0)20 3657 0050
 
IFC Advisory Limited (Financial PR and UK Investor Relations)
Tim Metcalfe / Graham Herring
Tel: +44 (0)20 3934 6630
Email: [email protected]
 

Edison Group (US Investor Relations)

Megan Paul

Tel: +1 (646) 653 7034

Email: [email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

SOURCE: Midatech Pharma PLC

Midatech Pharma PLC
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions